Daratumumab Shows Promise for Systemic Lupus Erythematosus Treatment
Depleting plasma cells with an anti-CD38 antibody led to ameliorations in multiple measures of systemic lupus erythematosus in an open-label phase 2 trial.
Read MoreDepleting plasma cells with an anti-CD38 antibody led to ameliorations in multiple measures of systemic lupus erythematosus in an open-label phase 2 trial.
Read MoreSchool-aged children who consume more soy foods may have improved thinking and attention,...
Read MoreThe first time Tammy and Jordan Myers held their twins, the premature babies were so fragile that their tiny faces were mostly covered by oxygen masks and tubing. Their little hands rested gently on Tammy’s chest as the...
Read MoreThe largest private company that brokers use to enroll people in Affordable Care Act health plans said it’s joining with insurers to thwart unauthorized Obamacare sign-ups and plan switches. HealthSherpa, which has its own...
Read More